Search - tctmd.com

Displaying 921 - 940 of 1676

Sort: Relevancy | Date

Presentation TVT 2016

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

Presenter: Philippe Généreux

June 17, 2016

Presentation TVT 2016

TAVR-Related Endocarditis: Incidence, Clinical Relevance, and Management

Presenter: Bernard Prendergast

June 17, 2016

Presentation TVT 2016

AS and the Patient With Hypertrophic Cardiomyopathy (With and Without Obstruction)

Presenter: Chet Rihal

June 17, 2016

Presentation TVT 2016

The Sentinel US Pivotal Clinical Trial Design

Presenter: Susheel Kodali

June 17, 2016

Presentation TVT 2016

AS and the Failing Bioprosthetic Mitral Valve

Presenter: Mathew Williams

June 17, 2016

Presentation TVT 2016

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2016

Severe LVOT Calcification and TAVR: Assessment and Procedural Decision Making

Presenter: Hasan Jilaihawi

June 17, 2016

Presentation TVT 2016

Severe LV Dysfunction and Severe AS: Diagnostic Tests and Procedural Choices

Presenter: Howard C. Herrmann

June 17, 2016

Presentation TVT 2016

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Presenter: Brij Maini

June 17, 2016

Presentation TVT 2016

Identifying the Futile AS Patient: When Are Extreme Comorbidities Too Much for TAVR?

Presenter: David J. Cohen

June 17, 2016

Presentation TVT 2016

The Bard TRUE Balloon: Design Features and Clinical Applications

Presenter: Jeffrey J. Popma

June 17, 2016

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

Presentation TVT 2016

The InterValve V8 Balloon: Design Features and Clinical Applications

Presenter: Wesley R. Pedersen

June 17, 2016

Presentation TVT 2016

The Management of Severe AS With a Small Aortic Annulus

Presenter: Josep Rodés-Cabau

June 17, 2016

Presentation TVT 2016

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

Presenter: Helene Eltchaninoff

June 17, 2016

Presentation TVT 2016

Clinical Decisions in Patients With Low-Gradient AS

Presenter: Allan Schwartz

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

Presentation TVT 2016

Study Design for the PARTNER 3 Low-Risk Trial

Presenter: Martin B. Leon

June 16, 2016

Advertisement

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

TAVR-Related Endocarditis: Incidence, Clinical Relevance, and Management

AS and the Patient With Hypertrophic Cardiomyopathy (With and Without Obstruction)

The Sentinel US Pivotal Clinical Trial Design

AS and the Failing Bioprosthetic Mitral Valve

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Severe LVOT Calcification and TAVR: Assessment and Procedural Decision Making

Severe LV Dysfunction and Severe AS: Diagnostic Tests and Procedural Choices

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Identifying the Futile AS Patient: When Are Extreme Comorbidities Too Much for TAVR?

The Bard TRUE Balloon: Design Features and Clinical Applications

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

The InterValve V8 Balloon: Design Features and Clinical Applications

The Management of Severe AS With a Small Aortic Annulus

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

Clinical Decisions in Patients With Low-Gradient AS

What TAVR Needs Next . . . and What It’s Getting

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Study Design for the PARTNER 3 Low-Risk Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content